Par-3 expression and regulation are considered largely involved in cancer cell migration, and a few studies have suggested defective expression or amplified PARD3 gene in prostate cancer cells [17], esophageal squamous cell carcinoma [18], neoplastic retinal pigment epithelial cells [19] and HCC [20]. This evidence concerns the gene PARD3 and hepatocellular carcinoma.